PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCaptopril
Captopril
Captopril (captopril) is a small molecule pharmaceutical. Captopril was first approved as Capoten on 1982-01-01. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
musculoskeletal diseasesD009140
urogenital diseasesD000091642
cardiovascular diseasesD002318
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Captopril (discontinued: Capoten, Captopril)
Combinations
Captopril hydrochlorothiazide (discontinued: Capozide, Captopril hydrochlorothiazide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Captopril
Tradename
Company
Number
Date
Products
CAPOTENStrides Pharma GlobalN-018343 DISCN1982-01-01
7 products, RLD
Hide discontinued
Captopril
+
Hydrochlorothiazide
Tradename
Company
Number
Date
Products
CAPOZIDE 25/15Bristol Myers SquibbN-018709 DISCN1984-10-12
1 products, RLD
CAPOZIDE 25/25Bristol Myers SquibbN-018709 DISCN1984-10-12
1 products, RLD
CAPOZIDE 50/25Bristol Myers SquibbN-018709 DISCN1984-10-12
1 products, RLD
CAPOZIDE 50/15Bristol Myers SquibbN-018709 DISCN1984-10-12
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
captoprilANDA2024-10-15
captopril and hydrochlorothiazideANDA2023-02-21
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C09: Agents acting on the renin-angiotensin system
— C09A: Ace inhibitors, plain
— C09AA: Ace inhibitors, plain
— C09AA01: Captopril
— C09B: Ace inhibitors, combinations
— C09BA: Ace inhibitors and diuretics
— C09BA01: Captopril and diuretics
HCPCS
No data
Clinical
Clinical Trials
90 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I106128723
HyperaldosteronismD006929HP_0011736E26———11011
Heart failureD006333HP_0001635I501—1237
Covid-19D000086382———22116
Kidney diseasesD007674EFO_0003086N08—12136
Type 2 diabetes mellitusD003924EFO_0001360E1111—315
Healthy volunteers/patients———3——1—4
Heart diseasesD006331EFO_0003777I51.9—1—113
Diabetes mellitusD003920HP_0000819E08-E13———123
Coronavirus infectionsD018352EFO_0007224B34.2—1—1—2
Show 31 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetic nephropathiesD003928EFO_0000401——13——3
Essential hypertensionD000075222—I10111—13
NeoplasmsD009369—C80221——3
PneumoniaD011014EFO_0003106——11——2
Type 1 diabetes mellitusD003922EFO_0001359E10——1—12
MalariaD008288EFO_0001068B54——1——1
Peripheral arterial diseaseD058729EFO_0004265———1——1
Arterial occlusive diseasesD001157EFO_0009085———1——1
LeukemiaD007938—C95——1——1
Myeloid leukemia acuteD015470—C92.0——1——1
Show 3 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Blood pressureD001794EFO_0004325—11———2
FibrosisD005355——12———2
StrokeD020521EFO_0000712I63.9—1——12
GlioblastomaD005909EFO_0000515—11———1
Sickle cell anemiaD000755EFO_0000697D57—1———1
Prostatic neoplasmsD011471—C61—1———1
Neoplasm metastasisD009362EFO_0009708—11———1
Myeloproliferative disordersD009196—D47.111———1
Primary myelofibrosisD055728—D47.411———1
Radiation injuriesD011832———1———1
Show 10 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pure autonomic failureD054970——2————2
CardiomyopathiesD009202EFO_0000318I421———12
Shy-drager syndromeD012791EFO_1001050—1————1
Multiple system atrophyD019578——1————1
Takotsubo cardiomyopathyD054549EFO_1002000I51.811————1
Pulmonary hypertensionD006976EFO_0001361I27.201————1
Pulmonary arterial hypertensionD000081029——1————1
Muscular dystrophiesD009136HP_0003560G71.01————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.0————22
Chronic renal insufficiencyD051436—N18————22
Mitral valve insufficiencyD008944HP_0001653—————22
AneurysmD000783HP_0002617I72.9————11
Thoracic aortic aneurysmD017545EFO_0004282—————11
Aortic aneurysmD001014EFO_0001666I71.9————11
Wounds and injuriesD014947—T14.8————11
Spinal cord injuriesD013119EFO_1001919—————11
Peri-implantitisD057873EFO_1001390—————11
Heart murmursD006337HP_0030148R01.0————11
Show 19 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCaptopril
INNcaptopril
Description
Captopril is a L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor and an antihypertensive agent. It is a pyrrolidinemonocarboxylic acid, a N-acylpyrrolidine, an alkanethiol and a L-proline derivative.
Classification
Small molecule
Drug classaptamers, classical and mirror; antihypertensives (ACE inhibitors)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
Identifiers
PDB—
CAS-ID62571-86-2
RxCUI—
ChEMBL IDCHEMBL1560
ChEBI ID3380
PubChem CID44093
DrugBankDB01197
UNII ID9G64RSX1XD (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Captopril
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Captopril
+
Hydrochlorothiazide
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 21,262 documents
View more details
Safety
Black-box Warning
Black-box warning for: Captopril, Captopril and hydrochlorothiazide
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,654 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use